These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2023736)

  • 41. Reliability of the first eye and second eye in frequency doubling technology perimetry.
    Mukai S; Tsukamoto H; Iwase A; Mishima HK
    Jpn J Ophthalmol; 2005; 49(5):417-9. PubMed ID: 16187045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence-based Criteria for Assessment of Visual Field Reliability.
    Yohannan J; Wang J; Brown J; Chauhan BC; Boland MV; Friedman DS; Ramulu PY
    Ophthalmology; 2017 Nov; 124(11):1612-1620. PubMed ID: 28676280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of missed catch trials on the visual field in normal subjects.
    Cascairo MA; Stewart WC; Sutherland SE
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):437-41. PubMed ID: 1937076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Misleading statistical calculations in far-advanced glaucomatous visual field loss.
    Blumenthal EZ; Sapir-Pichhadze R
    Ophthalmology; 2003 Jan; 110(1):196-200. PubMed ID: 12511366
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of SLO-Microperimetry and Humphrey for evaluating macular sensitivity changes in advanced glaucoma.
    Kulkarni SV; Coupland SG; Stitt DM; Hamilton J; Brownstein JJ; Damji KF
    Can J Ophthalmol; 2013 Oct; 48(5):406-12. PubMed ID: 24093188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of glaucoma-related visual field abnormality with the screening protocol of frequency doubling technology.
    Quigley HA
    Am J Ophthalmol; 1998 Jun; 125(6):819-29. PubMed ID: 9645719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short-wavelength automated perimetry in low-, medium-, and high-risk ocular hypertensive eyes. Initial baseline results.
    Johnson CA; Brandt JD; Khong AM; Adams AJ
    Arch Ophthalmol; 1995 Jan; 113(1):70-6. PubMed ID: 7826296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparison of the OKP visual field screening test with the Humphrey field analyser.
    Vernon SA; Quigley HA
    Eye (Lond); 1992; 6 ( Pt 5)():521-4. PubMed ID: 1286719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparison of false-negative responses for full threshold and SITA standard perimetry in glaucoma patients and normal observers.
    Johnson CA; Sherman K; Doyle C; Wall M
    J Glaucoma; 2014; 23(5):288-92. PubMed ID: 23632399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Blue-on-yellow visual field and retinal nerve fiber layer in ocular hypertension and glaucoma.
    Teesalu P; Airaksinen PJ; Tuulonen A
    Ophthalmology; 1998 Nov; 105(11):2077-81. PubMed ID: 9818609
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Visual Field Measurement with Heidelberg Edge Perimeter and Humphrey Visual Field Analyzer in Patients with Ocular Hypertension.
    Kaczorowski K; Mulak M; Szumny D; Baranowska M; Jakubaszko-Jabłońska J; Misiuk-Hojło M
    Adv Clin Exp Med; 2016; 25(5):937-944. PubMed ID: 28028959
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Frequency doubling technique in patients with ocular hypertension and glaucoma: correlation with octopus perimeter indices.
    Iester M; Mermoud A; Schnyder C
    Ophthalmology; 2000 Feb; 107(2):288-94. PubMed ID: 10690827
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Advanced Glaucoma Intervention Study. 2. Visual field test scoring and reliability.
    Ophthalmology; 1994 Aug; 101(8):1445-55. PubMed ID: 7741836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Motion automated perimetry identifies early glaucomatous field defects.
    Bosworth CF; Sample PA; Gupta N; Bathija R; Weinreb RN
    Arch Ophthalmol; 1998 Sep; 116(9):1153-8. PubMed ID: 9747672
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determining progressive visual field loss in serial Humphrey visual fields.
    Birch MK; Wishart PK; O'Donnell NP
    Ophthalmology; 1995 Aug; 102(8):1227-34; discussion 1234-5. PubMed ID: 9097752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A new chart to improve the efficiency of glaucoma detection by oculokinetic perimetry.
    Stirling RJ; MacLeod JD; Vernon SA
    Eye (Lond); 1994; 8 ( Pt 1)():121-4. PubMed ID: 8013705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suprathreshold static perimetry in glaucoma and other optic nerve disease.
    Johnson CA; Keltner JL; Balestrery FG
    Ophthalmology; 1979 Jul; 86(7):1278-86. PubMed ID: 233860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Concordance of parapapillary chorioretinal atrophy in ocular hypertension with visual field defects that accompany glaucoma development.
    Tezel G; Dorr D; Kolker AE; Wax MB; Kass MA
    Ophthalmology; 2000 Jun; 107(6):1194-9. PubMed ID: 10857843
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Automated perimetry detects visual field loss before manual Goldmann perimetry.
    Katz J; Tielsch JM; Quigley HA; Sommer A
    Ophthalmology; 1995 Jan; 102(1):21-6. PubMed ID: 7831036
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pseudo-loss of fixation in automated perimetry.
    Sanabria O; Feuer WJ; Anderson DR
    Ophthalmology; 1991 Jan; 98(1):76-8. PubMed ID: 2023737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.